TATAA specializes in cell and gene therapy bioanalytical assays and biomarker profiling for precision medicine through genomics, transcriptomics, and proteomics services. TATAA’s robust molecular analyses allow biopharma researchers to define drug targets, select patient populations, prioritize drug formulations, and prepare IND filings.
TATAA Biocenter is listed as one of Sweden’s fastest growing tech companies by accounting organization Deloitte. Sweden Technology Fast 50 includes public and private companies in all areas of technology
© Care Equity Capital Management L.P. New York, New York
